Get Your Personalized Supplement StackSupplement Stack Quiz

Bacillus Subtilus

Also known as: B. subtilis, hay bacillus, grass bacillus, Bacillus subtilis

Overview

Bacillus subtilis is a naturally occurring, spore-forming, Gram-positive bacterium widely utilized as a probiotic dietary supplement. Its unique ability to form resilient spores allows it to survive harsh environmental conditions, including gastric acid, ensuring its delivery to the gastrointestinal tract. Primarily, B. subtilis is employed to support gut health by modulating the gut microbiome and enhancing immune function. Research indicates its potential applications in alleviating gastrointestinal disorders, assisting in the management of metabolic diseases, and contributing to infectious disease prevention. The evidence base, while growing, includes randomized controlled trials, systematic reviews, and meta-analyses, though the extent of clinical research varies across different indications.

Benefits

Bacillus subtilis offers several evidence-based benefits. For gastrointestinal health, systematic reviews and randomized controlled trials (RCTs) suggest it can significantly reduce symptoms of functional abdominal bloating and distention, improving quality of life related to intestinal gas. In the context of Metabolic Associated Fatty Liver Disease (MAFLD), a meta-analysis of RCTs demonstrated that combined interventions including B. subtilis and Enterococcus faecium improved liver function, metabolic parameters, and reduced inflammation. While primarily studied in animal models, meta-analyses have shown B. subtilis supplementation can improve feed conversion ratio and reduce lesion scores in poultry with necrotic enteritis. Furthermore, systematic reviews and meta-analyses confirm its antagonistic activity against certain fungi, indicating potential broader antimicrobial properties. Effect sizes are generally statistically significant, with moderate to large confidence intervals, though specific benefits and their strength of evidence can vary by study and population.

How it works

Bacillus subtilis exerts its beneficial effects primarily through its ability to form spores that germinate within the gastrointestinal tract. Once germinated, it produces various enzymes and antimicrobial peptides that inhibit the growth of pathogenic bacteria and fungi, thereby helping to maintain a balanced gut microbiome. It also modulates host immune responses, contributing to reduced inflammation and enhanced gut barrier function. In metabolic diseases, B. subtilis may influence lipid metabolism and inflammatory signaling pathways. The inherent resistance of its spores to gastric acid ensures high bioavailability and effective colonization potential within the intestines, allowing its mechanisms of action to be fully realized.

Side effects

Bacillus subtilis is generally considered safe for consumption, with clinical trials reporting no serious adverse events. Mild gastrointestinal discomfort, such as gas or bloating, is rare but can occur. There are no documented significant drug interactions or contraindications in high-quality studies. However, its safety in immunocompromised populations has not been extensively studied and warrants further research. As with any supplement, individuals with underlying health conditions or those taking other medications should consult a healthcare professional before use. Overall, its safety profile is robust, making it a well-tolerated probiotic for most healthy adults.

Dosage

Effective dosages of Bacillus subtilis in clinical trials typically range from approximately 10^8 to 10^10 colony-forming units (CFU) per day. The timing of administration can vary, and some formulations, particularly enteric-coated ones, may enhance delivery to the intestines. Optimal dosing can depend on the specific health indication and the product formulation; for instance, studies on MAFLD often utilize combined probiotic capsules with specific CFU counts of multiple strains. While there is no established maximum safe dose, doses within the studied ranges have been consistently well tolerated in clinical settings. It is advisable to follow product-specific recommendations or consult a healthcare professional for personalized guidance.

FAQs

Is Bacillus subtilis effective for gut health?

Yes, evidence supports its benefits in reducing bloating and improving gut symptoms, particularly functional abdominal bloating and distention.

Is it safe?

Yes, Bacillus subtilis has a strong safety profile in healthy adults, with no serious adverse events reported in clinical trials.

How quickly do benefits appear?

Symptom improvements have been observed within 4 to 8 weeks in clinical trials, though individual responses may vary.

Can it be combined with other probiotics?

Yes, combined formulations with other strains, such as Enterococcus faecium, are common and have shown effectiveness in studies.

Research Sources

https://bioresources.cnr.ncsu.edu/resources/evaluation-of-the-antagonistic-effect-and-influencing-factors-of-bacillus-subtilis-against-wood-stain-fungi-a-systematic-literature-review-and-meta-analysis-approach/ – This systematic review and meta-analysis confirmed the antagonistic effect of B. subtilis against wood stain fungi in multiple in vitro studies. It highlighted dose-dependent effects and provided a comprehensive overview of factors influencing this antimicrobial activity, though it noted limitations for clinical translation due to its in vitro nature.
https://brill.com/view/journals/bm/16/3/article-p281_2.xml – This pilot randomized controlled trial involving approximately 100 adults with functional abdominal bloating demonstrated a significant reduction in gas-related symptoms and their impact on daily life after 8 weeks of B. subtilis supplementation. The study suggests B. subtilis can improve quality of life for individuals experiencing these gastrointestinal issues.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1610426/full – This meta-analysis of randomized controlled trials in MAFLD patients found that combined probiotic capsules, including B. subtilis, significantly improved liver function, metabolic markers, and reduced inflammation. It suggests a beneficial role for B. subtilis in managing metabolic associated fatty liver disease, although the effect of B. subtilis alone was not isolated.
https://pubmed.ncbi.nlm.nih.gov/38776185/?fc=None&ff=20240523024845&v=2.18.0.post9+e462414 – This meta-analysis of RCTs in poultry with necrotic enteritis showed that B. subtilis supplementation improved feed conversion ratio and reduced lesion scores. While it did not significantly affect mortality, the findings suggest a role for B. subtilis in improving gut health and performance in animal models, though human inference is limited.